Y.B Urban Renewal - Residential Development LTD Logo

Y.B Urban Renewal - Residential Development LTD

CSURE-M | TA

Overview

Corporate Details

ISIN(s):
IL0001110134
LEI:
Country:
Israel
Address:
2 Hahadarim Street, 7712102 Ashdod
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cannassure-M focuses on the development and production of medical cannabis products in Israel.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 19:43
Regulatory News Service
Trading in the company's shares (ISIN IL0001110134) will be renewed on Monday, …
Hebrew (modern) 113.5 KB
2025-05-05 15:53
Regulatory News Service
The securities not included in the Illiquid list as of May 4th 2025 due to mar…
Hebrew (modern) 217.1 KB
2025-05-05 11:32
Regulatory News Service
Suspension of trading due to failure in publication of financial reports s for …
Hebrew (modern) 79.7 KB
2025-04-28 18:40
Regulatory News Service
Securities that have joined the program and the Market Makers that will operate…
Hebrew (modern) 366.8 KB
2025-04-20 18:21
Regulatory News Service
Failure in publishing financial reports-Notification
Hebrew (modern) 128.0 KB
2025-03-06 18:39
Regulatory News Service
Illiquid Candidates securities list as of May 4th 2025
Hebrew (modern) 245.6 KB
2024-07-28 18:05
Regulatory News Service
The company's securities will be transferred from the maintenance list to the m…
Hebrew (modern) 106.5 KB
2024-07-11 17:14
Regulatory News Service
Changes in the company's share symbol correction: YBRD-M
Hebrew (modern) 104.0 KB
2024-07-09 17:01
Regulatory News Service
Changes in the company's name and security, effective as of July 11, 2024
Hebrew (modern) 105.9 KB
2024-06-25 19:48
Regulatory News Service
Changes in Sector Classification of Listed Companies as of Sunday, June 30, 2024
Hebrew (modern) 135.9 KB
2024-03-21 18:45
Regulatory News Service
Will trade on Monday March 25 2024, with unlimited price fluctuation at the ope…
Hebrew (modern) 137.2 KB
2023-07-13 20:43
Regulatory News Service
Transfer to the Maintenance List on July 17, 2023
Hebrew (modern) 149.7 KB
2023-07-03 19:48
Regulatory News Service
Companies that do not comply with the Maintenance Rules and are candidates to b…
Hebrew (modern) 116.3 KB
2023-01-15 17:37
Regulatory News Service
Non-Compliance with the Maintenance Rules Based on Data as of December 31, 2022…
Hebrew (modern) 132.9 KB
2021-01-07 15:45
Regulatory News Service
On Sunday, 10 January 2021, trading will commence in the following Security: CA…
Hebrew (modern) 186.1 KB

Automate Your Workflow. Get a real-time feed of all Y.B Urban Renewal - Residential Development LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Y.B Urban Renewal - Residential Development LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Y.B Urban Renewal - Residential Development LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.